The Asia Pacific Plasma Protein Therapeutics Market would witness market growth of 6.6% CAGR during the forecast period (2023-2029).
Patients can live longer, better lives using medications derived from plasma that replace missing or insufficient proteins. People who rely on these treatments usually require injections or infusions throughout their lifetimes. The illnesses and disorders that can be treated using plasma proteins are classified as rare diseases since they only affect a few people. The majority of these illnesses are chronic, inherited illnesses. Some common illnesses treated by plasma protein include hemophilia, idiopathic thrombocytopenic purpura, primary immunodeficiency disorder, etc.
The symptoms of this ailment in its victims include joint bleeding and other problems. Hemophilia A mainly affects men since the faulty gene is on the X chromosome. A woman's male kids will have a 50% risk of having hemophilia A, and her female offspring will have a 50% chance of harboring the faulty gene. There is an influence on every 10,000 people. After undergoing treatment, patients can lead fairly typical lives. A factor IX gene mutation results in hemophilia B, also a blood clotting condition. Though Less frequent than hemophilia A, it is widely known to affect royal families in Russia and Europe.
The Asia Pacific Society for Immunodeficiencies (APSID) was formed in Osaka in 2015 and established in Hong Kong in 2016 to support the growth of PID care and training in the Asia Pacific region. Between 2015 and 2020, APSID held PID Schools ("Schools") for Asia Pacific early-career medical professionals and scientists ("students"). To broaden the Schools' influence within the medical community, some schools were held concurrently with international or national conferences hosted by immunologic or pediatric groups. As a result of all these elements, there is a higher demand for plasma protein therapeutics to treat PID as well as other chronic and rare illnesses, which is boosting the expansion of the market.
The China market dominated the Asia Pacific Plasma Protein Therapeutics Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $2,634.4 Million by 2029. The Japan market is estimated to grow a CAGR of 6% during (2023 - 2029). Additionally, The India market would experience a CAGR of 7.3% during (2023 - 2029).
Based on End User, the market is segmented into Hospitals, and Others. Based on Product Type, the market is segmented into Immunoglobulin, Albumin, Plasma derived factor VIII, and Others. Based on Application, the market is segmented into Hemophilia, Idiopathic Thrombocytopenic Purpura, Primary Immunodeficiency Disorder, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Plasma Protein Therapeutics Market is Projected to reach USD 39.1 Billion by 2029, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Abeona Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Grifols, S.A., Baxter International, Inc., Kedrion S.p.A, Octapharma AG, CSL Limited (CSL Behring), Taibang Biological Group Co., Ltd and ADMA Biologics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
By Product Type
- Immunoglobulin
- Albumin
- Plasma derived factor VIII
- Others
By Application
- Hemophilia
- Idiopathic Thrombocytopenic Purpura
- Primary Immunodeficiency Disorder
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Bayer AG
- Abeona Therapeutics, Inc.
- Takeda Pharmaceutical Company Limited
- Grifols, S.A.
- Baxter International, Inc.
- Kedrion S.p.A
- Octapharma AG
- CSL Limited (CSL Behring)
- Taibang Biological Group Co., Ltd
- ADMA Biologics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Plasma Protein Therapeutics Market, by End User
1.4.2 Asia Pacific Plasma Protein Therapeutics Market, by Product Type
1.4.3 Asia Pacific Plasma Protein Therapeutics Market, by Application
1.4.4 Asia Pacific Plasma Protein Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Acquisitions and Mergers : 2020, Jun – 2023, Mar) Leading Players
Chapter 4. Asia Pacific Plasma Protein Therapeutics Market by End User
4.1 Asia Pacific Hospitals Market by Country
4.2 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Plasma Protein Therapeutics Market by Product Type
5.1 Asia Pacific Immunoglobulin Market by Country
5.2 Asia Pacific Albumin Market by Country
5.3 Asia Pacific Plasma derived factor VIII Market by Country
5.4 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Plasma Protein Therapeutics Market by Application
6.1 Asia Pacific Hemophilia Market by Country
6.2 Asia Pacific Idiopathic Thrombocytopenic Purpura Market by Country
6.3 Asia Pacific Primary Immunodeficiency Disorder Market by Country
6.4 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Plasma Protein Therapeutics Market by Country
7.1 China Plasma Protein Therapeutics Market
7.1.1 China Plasma Protein Therapeutics Market by End User
7.1.2 China Plasma Protein Therapeutics Market by Product Type
7.1.3 China Plasma Protein Therapeutics Market by Application
7.2 Japan Plasma Protein Therapeutics Market
7.2.1 Japan Plasma Protein Therapeutics Market by End User
7.2.2 Japan Plasma Protein Therapeutics Market by Product Type
7.2.3 Japan Plasma Protein Therapeutics Market by Application
7.3 India Plasma Protein Therapeutics Market
7.3.1 India Plasma Protein Therapeutics Market by End User
7.3.2 India Plasma Protein Therapeutics Market by Product Type
7.3.3 India Plasma Protein Therapeutics Market by Application
7.4 South Korea Plasma Protein Therapeutics Market
7.4.1 South Korea Plasma Protein Therapeutics Market by End User
7.4.2 South Korea Plasma Protein Therapeutics Market by Product Type
7.4.3 South Korea Plasma Protein Therapeutics Market by Application
7.5 Singapore Plasma Protein Therapeutics Market
7.5.1 Singapore Plasma Protein Therapeutics Market by End User
7.5.2 Singapore Plasma Protein Therapeutics Market by Product Type
7.5.3 Singapore Plasma Protein Therapeutics Market by Application
7.6 Malaysia Plasma Protein Therapeutics Market
7.6.1 Malaysia Plasma Protein Therapeutics Market by End User
7.6.2 Malaysia Plasma Protein Therapeutics Market by Product Type
7.6.3 Malaysia Plasma Protein Therapeutics Market by Application
7.7 Rest of Asia Pacific Plasma Protein Therapeutics Market
7.7.1 Rest of Asia Pacific Plasma Protein Therapeutics Market by End User
7.7.2 Rest of Asia Pacific Plasma Protein Therapeutics Market by Product Type
7.7.3 Rest of Asia Pacific Plasma Protein Therapeutics Market by Application
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Grifols, S.A
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.5.4 Geographical Expansions:
8.3 Takeda Pharmaceutical Company Limited
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Geographical Expansions:
8.4 Kedrion S.p.A
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 ADMA Biologics, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals and Trials:
8.6 Octapharma AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Approvals and Trials:
8.7 CSL Limited (CSL Behring)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Baxter International, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expense
8.9 Abeona Therapeutics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Expenses
8.10. Taibang Biologic Group
8.10.1 Company Overview
TABLE 1 Asia Pacific Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Plasma Protein Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Plasma Protein Therapeutics Market
TABLE 5 Acquisition and Mergers– Plasma Protein Therapeutics Market
TABLE 6 Geographical expansions – Plasma Protein Therapeutics Market
TABLE 7 approvals and trials – Plasma Protein Therapeutics Market
TABLE 8 Asia Pacific Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 9 Asia Pacific Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 10 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 11 Asia Pacific Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 12 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 13 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 14 Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 15 Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 16 Asia Pacific Immunoglobulin Market by Country, 2019 - 2022, USD Million
TABLE 17 Asia Pacific Immunoglobulin Market by Country, 2023 - 2029, USD Million
TABLE 18 Asia Pacific Albumin Market by Country, 2019 - 2022, USD Million
TABLE 19 Asia Pacific Albumin Market by Country, 2023 - 2029, USD Million
TABLE 20 Asia Pacific Plasma derived factor VIII Market by Country, 2019 - 2022, USD Million
TABLE 21 Asia Pacific Plasma derived factor VIII Market by Country, 2023 - 2029, USD Million
TABLE 22 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 23 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 24 Asia Pacific Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 25 Asia Pacific Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 26 Asia Pacific Hemophilia Market by Country, 2019 - 2022, USD Million
TABLE 27 Asia Pacific Hemophilia Market by Country, 2023 - 2029, USD Million
TABLE 28 Asia Pacific Idiopathic Thrombocytopenic Purpura Market by Country, 2019 - 2022, USD Million
TABLE 29 Asia Pacific Idiopathic Thrombocytopenic Purpura Market by Country, 2023 - 2029, USD Million
TABLE 30 Asia Pacific Primary Immunodeficiency Disorder Market by Country, 2019 - 2022, USD Million
TABLE 31 Asia Pacific Primary Immunodeficiency Disorder Market by Country, 2023 - 2029, USD Million
TABLE 32 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 33 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 34 Asia Pacific Plasma Protein Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 35 Asia Pacific Plasma Protein Therapeutics Market by Country, 2023 - 2029, USD Million
TABLE 36 China Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 37 China Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 38 China Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 39 China Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 40 China Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 41 China Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 42 China Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 43 China Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 44 Japan Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 45 Japan Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 46 Japan Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 47 Japan Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 48 Japan Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 49 Japan Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 50 Japan Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 51 Japan Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 52 India Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 53 India Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 54 India Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 55 India Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 56 India Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 57 India Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 58 India Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 59 India Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 60 South Korea Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 61 South Korea Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 62 South Korea Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 63 South Korea Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 64 South Korea Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 65 South Korea Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 66 South Korea Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 67 South Korea Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 68 Singapore Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 69 Singapore Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 70 Singapore Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 71 Singapore Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 72 Singapore Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 73 Singapore Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 74 Singapore Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 75 Singapore Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 76 Malaysia Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 77 Malaysia Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 78 Malaysia Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 79 Malaysia Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 80 Malaysia Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 81 Malaysia Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 82 Malaysia Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 83 Malaysia Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 84 Rest of Asia Pacific Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 85 Rest of Asia Pacific Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 86 Rest of Asia Pacific Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 87 Rest of Asia Pacific Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 88 Rest of Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 89 Rest of Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 90 Rest of Asia Pacific Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 91 Rest of Asia Pacific Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 92 Key Information – Bayer AG
TABLE 93 Key information – Grifols, S.A.
TABLE 94 Key Information – Takeda Pharmaceutical Company Limited
TABLE 95 key Information – Kedrion S.p.A
TABLE 96 Key Information – ADMA Biologics, Inc.
TABLE 97 Key Information – Octapharma AG
TABLE 98 key Information – CSL Limited
TABLE 99 Key Information – Baxter International, Inc.
TABLE 100 Key Information – Abeona Therapeutics, Inc.
TABLE 101 Key Information – Taibang Biologic Group
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Acquisitions and Mergers : 2020, Jun – 2023, Mar) Leading Players
FIG 5 Swot analysis: bayer ag
FIG 6 Recent strategies and developments: Grifols, S.A.
FIG 7 Recent strategies and developments: Takeda Pharmaceutical Company Limited
FIG 8 Recent strategies and developments: Kedrion S.p.A